DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

11,100

Employees11,100

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

11,100

Employees11,100

DXCM Key Statistics

Market cap

33.92B

Market cap33.92B

Price-Earnings ratio

34.46

Price-Earnings ratio34.46

Dividend yield

—

Dividend yield—

Average volume

6.57M

Average volume6.57M

High today

$89.56

High today$89.56

Low today

$87.06

Low today$87.06

Open price

$87.56

Open price$87.56

Volume

5.87M

Volume5.87M

52 Week high

$89.56

52 Week high$89.56

52 Week low

$54.11

52 Week low$54.11

Stock Snapshot

DexCom(DXCM) stock is priced at $88.90, giving the company a market capitalization of 33.92B. It carries a P/E multiple of 34.46.

During the trading session on 2026-08-11, DexCom(DXCM) shares reached a daily high of $89.56 and a low of $87.06. At a current price of $88.90, the stock is +2.1% higher than the low and still -0.7% under the high.

Trading volume for DexCom(DXCM) stock has reached 5.87M, versus its average volume of 6.57M.

The stock's 52-week range extends from a low of $54.11 to a high of $89.56.

DXCM News

Simply Wall St 22h

Stronger Q2 Results and Higher 2026 Outlook Might Change The Case For Investing In DexCom

In July 2026, DexCom, Inc. reported second-quarter results showing higher sales of US$1,308.4 million and increased net income of US$249.1 million compared with...

MarketWatch 1d

DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Simply Wall St 6d

DexCom Raised Full Year Guidance, Is The Upside Already Priced In?

DexCom (DXCM) drew fresh attention after reporting second quarter 2026 results with higher sales and earnings, and raised full year revenue guidance to a range...

Analyst ratings

84%

of 31 ratings

Buy

83.9%

Hold

16.1%

Sell

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.